| pubmed-article:11378366 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11378366 | lifeskim:mentions | umls-concept:C0210158 | lld:lifeskim |
| pubmed-article:11378366 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:11378366 | lifeskim:mentions | umls-concept:C1554184 | lld:lifeskim |
| pubmed-article:11378366 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:11378366 | pubmed:dateCreated | 2001-5-29 | lld:pubmed |
| pubmed-article:11378366 | pubmed:abstractText | A series of aryloxy substituted piperazinones with dual farnesyltransferase/geranylgeranyltransferase-I inhibitory activity was prepared. These compounds were found to have potent inhibitory activity in vitro and are promising agents for the inhibition of Ki-Ras signaling. | lld:pubmed |
| pubmed-article:11378366 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11378366 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11378366 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11378366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11378366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11378366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11378366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11378366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11378366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11378366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11378366 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11378366 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:11378366 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:HuberH EHE | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:RobinsonR GRG | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:WilliamsT MTM | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:DavideJ PJP | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:GrahamS LSL | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:BuserC ACA | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:KohlN ENE | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:HartmanG DGD | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:KoblanK SKS | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:LobellR BRB | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:AbramsM TMT | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:BergmanJ MJM | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:DinsmoreC JCJ | lld:pubmed |
| pubmed-article:11378366 | pubmed:author | pubmed-author:GreenbergI... | lld:pubmed |
| pubmed-article:11378366 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11378366 | pubmed:day | 4 | lld:pubmed |
| pubmed-article:11378366 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:11378366 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11378366 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11378366 | pubmed:pagination | 1411-5 | lld:pubmed |
| pubmed-article:11378366 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:meshHeading | pubmed-meshheading:11378366... | lld:pubmed |
| pubmed-article:11378366 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11378366 | pubmed:articleTitle | Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. | lld:pubmed |
| pubmed-article:11378366 | pubmed:affiliation | Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. | lld:pubmed |
| pubmed-article:11378366 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:11378366 | lld:chembl |
